Serum methylated SST was significantly associated with cancer-specific survival among all other detected markers tested in the same study (TAC1, MAL, SEPT9, NELL1, CRABP1, EYA4, and CEA) at the preoperative time point, while its methylation status after operation had no value on prognosis [13, 28]. This evidence concerns the gene SEPTIN9 and cancer.